Osteoprotegerin serum levels in multiple myeloma and MGUS patients compared with age- and sex-matched healthy controls

被引：12

作者：

Corso, A

Dovio, A

Rusconi, C

Sartori, ML

Klersy, C

Varettoni, M

Mangiacavalli, S

Zappasodi, P

Ventura, M

Angeli, A

Lazzarino, M

机构：

[1] Univ Pavia, Policlin San Matteo, IRCCS, Div Hematol, I-27100 Pavia, Italy

[2] Univ Turin, Dipartimento Sci Clin & Biol, I-10124 Turin, Italy

[3] Univ Pavia, Div Hematol Biometry & Clin Epidemiol, I-27100 Pavia, Italy

来源：

LEUKEMIA | 2004年 / 18卷 / 09期

关键词：

D O I：

10.1038/sj.leu.2403429

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1555 / 1557

页数：4

共 9 条

[1]

Dovio A, 2003, CLIN CANCER RES, V9, P2384

[2]

DOVIO A, 2002, CLIN CANCER RES, V8, P2306

[3]

KRAJ M, 2003, HEMATOLOGY J S1, V4, pS157

[4] The αvβ3 integrin, NF-κB, osteoprotegerin endothelial cell survival pathway -: Potential role in angiogenesis [J].

Scatena, MT ;

Giachelli, C .

TRENDS IN CARDIOVASCULAR MEDICINE, 2002, 12 (02) :83-88

[5] Serum osteoprotegerin levels are reduced in patients with multiple myeloma with lytic bone disease [J].

Seidel, C ;

Hjertner, O ;

Abildgaard, N ;

Heickendorff, L ;

Hjorth, M ;

Westin, J ;

Nielsen, JL ;

Hjorth-Hansen, H ;

Waage, A ;

Sundan, A ;

Borset, M .

BLOOD, 2001, 98 (07) :2269-2271

[6] RANK ligand and osteoprotegerin in myeloma bone disease [J].

Sezer, O ;

Heider, U ;

Zavrski, I ;

Kühne, CA ;

Hofbauer, LC .

BLOOD, 2003, 101 (06) :2094-2098

[7] Osteoprotegerin is bound, internalized, and degraded by multiple myeloma cells [J].

Standal, T ;

Seidel, C ;

Hjertner, O ;

Plesner, T ;

Sanderson, RD ;

Waage, A ;

Borset, M ;

Sundan, A .

BLOOD, 2002, 100 (08) :3002-3007

[8] Soluble receptor activator of nuclear factor κB ligand-osteoprotegerin ratio predicts survival in multiple myeloma:: proposal for a novel prognostic index [J].

Terpos, E ;

Szydio, R ;

Apperley, JF ;

Hatjiharissi, A ;

Politou, M ;

Meletis, J ;

Viniou, N ;

Yataganas, X ;

Goldman, JM ;

Rahemtulla, A .

BLOOD, 2003, 102 (03) :1064-1069

[9] Increased serum osteoprotegerin in disorders characterized by persistent immune activation or glucocorticoid excess -: possible role in bone homeostasis [J].

Ueland, T ;

Bollerslev, J ;

Godang, K ;

Müller, F ;

Froland, SS ;

Aukrust, P .

EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2001, 145 (06) :685-690

← 1 →